Article Details
Retrieved on: 2021-09-29 16:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
John R. Birge: The data showed us that rosiglitazone was not associated ... the FDA were to use a more data-driven approach in its postmarket drug analysis, ...
Article found on: review.chicagobooth.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here